Consequently, in obese men, chronic treatment using GLP-1 receptor agonists (GLP-1 RAs) has been found to improve reproductive hormone levels, particularly in obese males with type 2 diabetes and hypogonadism [1-5,14-20,26]. Here, GLP1R is linked to hypogonadism.